Jennison Associates
RPID icon

Jennison Associates’s Rapid Micro Biosystems RPID Stock Holding History

Jennison Associates’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-123,605
Closed -$2.28M – 717
2021
Q3 		$2.28M Buy
+123,605
New +$2.55M ﹤0.01% 524

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jennison Associates's RPID Position: Q4 2021 in Review

Jennison Associates sold out of Rapid Micro Biosystems (RPID) in Q4 2021, closing a stake of 123,605 shares — an estimated $2.28M sold.

Jennison Associates first reported a position in RPID in Q3 2021 and held it in 1 quarter. The position peaked at $2.28M in Q3 2021. 55 funds tracked by Wall St. Rank hold RPID as of Q4 2021.

  • Jennison Associates reported no remaining Rapid Micro Biosystems position as of Q4 2021 after selling out during the quarter.
  • Jennison Associates sold 123,605 Rapid Micro Biosystems shares in Q4 2021, an estimated $2.28M.
  • Jennison Associates first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 1 quarter.
  • Jennison Associates's Rapid Micro Biosystems position peaked at $2.28M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2021.

Based on Jennison Associates's 13F filing for Q4 2021, filed 8 Feb 2022.